Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress

This publication has 54 references indexed in Scilit:

• Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors
  Expert Opinion on Investigational Drugs, 2006
• Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test
  European Neuropsychopharmacology, 2005
• Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
  Journal of Clinical Investigation, 2005
• STRUCTURE AND FUNCTION OF FATTY ACID AMIDE HYDROLASE
  Annual Review of Biochemistry, 2005
• Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress
  Neuropsychopharmacology, 2004
• The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
  European Journal of Neuroscience, 2002
• Formation and inactivation of endogenous cannabinoid anandamide in central neurons
  Nature, 1994
• Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
  Science, 1992